VGLL1 and prostate carcinoma: Echoing its role in the placenta, VGLL1 expression has previously been linked to increased cell proliferation in basal-like breast cancer, estrogen receptor-positive breast cancer, gastric cancer, pancreatic cancer, prostate cancer and HPV-related cervical cancer (8–12, 24).